Aimmune Therapeutics, maker of a peanut allergy treatment, said Monday that it will be acquired by the food conglomerate Nestle, which is seeking to expand its health sciences unit. […]
https://www.statnews.com/2020/02/03/new-peanut-allergy-treatment-palforzia-commercial-success-not-assured/